Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer


Korkmaz E. T. , KÖKSAL D. , Aksu F., DİKMEN Z. G. , İÇEN D. , Maden E., ...Daha Fazla

CLINICAL BIOCHEMISTRY, cilt.58, ss.15-19, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 58
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1016/j.clinbiochem.2018.05.001
  • Dergi Adı: CLINICAL BIOCHEMISTRY
  • Sayfa Sayıları: ss.15-19

Özet

Background and aim: Early diagnosis and histological subtyping are important issues in the management of patients with lung cancer (LC). The aim of this study is to investigate the diagnostic value of a panel of serum tumor markers in newly diagnosed patients with LC.